Conduct HIT-to-lead progression studies on interventional agents: identification of anti-HIV lead compounds (task area a)
Ended Awarded Last action
- Contract number
- 75N93021F00004
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $404,140
Award facts
- Opportunity
-
- 75N93021F00004 Solicitation number
- Contract value 100% obligated
- $404,140.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $404,140 |
About this award
This is a cost-plus-fixed-fee delivery order awarded to Southern Research Institute by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $404,140 contract is to conduct hit-to-lead progression studies on interventional agents for the identification of anti-HIV lead compounds under the agency's Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. The contract has no set-aside designation and the ultimate completion date is January 31, 2025. Southern Research Institute, a non-profit research organization, has previously been awarded prime and subcontracts with various federal agencies including NIH, CDC, DoD, and EPA for drug discovery, assay development, and other preclinical research services.
Quick answers
Who was awarded contract 75N93021F00004?
75N93021F00004 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2021.
How much is contract 75N93021F00004 worth?
The government has obligated $404,140 on 75N93021F00004.
Is contract 75N93021F00004 an order under another contract?
Yes. 75N93021F00004 is a delivery order under 75N93021D00010, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00004 competed?
The extent of competition for 75N93021F00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award